Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ · Manufacturing · Pharmaceutical preparations
AVIR price, last 12 months
Key stats
- Previous close
- $3.99
- Open
- $3.97
- Day range
- $3.91 – $4.05
- 52-week range
- $2.93 – $6.45
- Volume
- 291.3K
- Avg volume (20 days)
- 299.9K
- Market cap
- $345.3M
Performance
Technicals and fundamentals
About Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $345.3M